Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

High levels of androgens during early development may cause PCOS-like symptoms.

Early balding men may have insulin resistance, but lifestyle changes can help.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

Minoxidil metabolizes similarly in monkeys and humans, but differently in dogs and rats.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

Low-oxygen conditions and ECM degradation products increase the healing abilities of perivascular stem cells.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Substance from human umbilical cord blood cells promotes hair growth.

A special mix from certain skin cells can help hair grow by making hair root cells grow faster and activating growth signals.